Hem › Juvenil myelomonocyt leukemi › Illinois
Kliniska studier för Juvenil myelomonocyt leukemi i Illinois
3 studier för Juvenil myelomonocyt leukemi söker deltagare vid platser i Illinois.
Städer i Illinois
Officiell studietext (engelska)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 1/2
1 Month – 21 Years · Alla kön · Uppdaterad 4 sep. 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- Lurie Children's Hospital-Chicago, Chicago
RekryterarFas 1
Ålder 1 till 18 · Alla kön · Uppdaterad 25 aug. 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- och 6 fler
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.